# 2025-19058: South Carolina Doc Loses License Over Bad Prescriptions

2025-19058, Henry Emery, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-09-30, effective 2025-10-30 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19058
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19058
- Title: Henry Emery, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 46927
- Published: 2025-09-30
- Effective: 2025-10-30
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

South Carolina Doc Loses License Over Bad Prescriptions

## Summary

Dr. Henry Emery lost his permission to handle controlled substances in South Carolina and North Carolina because he no longer has legal authority in those states and allegedly prescribed drugs improperly. The DEA officially revoked his registrations after he didn’t respond to their orders. This means Dr. Emery can’t legally prescribe or handle controlled substances in these states anymore, effective immediately.

## Effects PRIA read

- DEA Registrations Revoked in SC and NC: cost, high. The Drug Enforcement Administration revoked Henry Emery, M.D.'s DEA registrations No. FE7195452 (South Carolina) and No. BE7654127 (North Carolina), effective October 30, 2025. Because his South Carolina medical license was suspended on March 14, 2024, and he entered an Interim Non‑Practice Agreeme…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19058 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/30/2025-19058/henry-emery-md-decision-and-order)
- [2025-19058 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-30/pdf/2025-19058.pdf)

## Related
- [Previous: 2025-19057, Self-Regulatory Organizations; 24X National Exchange LLC; Notice of Filing and…](https://policyrisk.com/federal-register/2025-19057)
- [Next: 2025-19059, Self-Regulatory Organizations; National Securities Clearing Corporation; Notice…](https://policyrisk.com/federal-register/2025-19059)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19058 (as of 2026-06-08).
